What Causes Infection in Vasculitis?
What Causes Infection in Vasculitis? tammytilley@gm… Tue, 10/28/2025 – 19:44 Education/ACR/EULAR Infection Vasculitis Dr. David Liew reports on abstract 2526 […]
RheumNow
Progressive BiTE in SLE 2
Progressive BiTE in SLE 2 tammytilley@gm… Tue, 10/28/2025 – 19:30 Lupus Dr. Yuz Yusof reports on abstract 0646 (A-319, a
Catching PsA before it Starts
Catching PsA before it Starts tammytilley@gm… Tue, 10/28/2025 – 19:15 Psoriatic arthritis Dr. Aurelie Najm reporting on abstract 0877 presented
Biomarker Discovery in axSpA
Biomarker Discovery in axSpA tammytilley@gm… Tue, 10/28/2025 – 19:00 Spondyloarthritis Labs/Biomarkers Dr. Atul Deodhar offers his perspective on studies in
RheumNow
We often see patients with MTX lab abnormalities but How frequent is MTX toxicity? Retrospective study 2500pts Rocheste
We often see patients with MTX lab abnormalities but How frequent is MTX toxicity? Retrospective study 2500pts Rocheste https://pbs.twimg.com/profile_images/1800478984926334976/yyyPLP4A_normal.jpg john+RNV2@john…
RheumNow
Lung Disease in ANCA-associated Vasculitis Dr. Mike Putman discusses abstract 0721, “Pulmonary Manifestations of Granu
Lung Disease in ANCA-associated Vasculitis Dr. Mike Putman discusses abstract 0721, “Pulmonary Manifestations of Granu https://pbs.twimg.com/profile_images/1915149062988271616/2m4z_QPt_normal.jpg john+RNV2@john… Tue, 10/28/2025 –
Wired for Success: Vagal Nerve Therapy in RA
Wired for Success: Vagal Nerve Therapy in RA tammytilley@gm… Tue, 10/28/2025 – 18:17 Rheumatoid Arthritis Dr. Aurelie Najm reporting on
Is it All About the Weight Loss?
Is it All About the Weight Loss? tammytilley@gm… Tue, 10/28/2025 – 18:14 Education/ACR/EULAR General Rheumatology Outcomes Dr. Jeffrey Curtis discusses
IgG4: Rare but Treatable!
IgG4: Rare but Treatable! tammytilley@gm… Tue, 10/28/2025 – 17:49 Education/ACR/EULAR JAK/TYK2 Novel Rx Outcomes Rare Diseases Steroids Dr. Janet Pope
RheumNow
ACR2025 Day 3 Recap https://t.co/ZQ1mZePZ1S
ACR2025 Day 3 Recap https://t.co/ZQ1mZePZ1S https://pbs.twimg.com/profile_images/1915149062988271616/2m4z_QPt_normal.jpg john+RNV2@john… Tue, 10/28/2025 – 18:00 RheumNow Dr. John Cush ACR2025 Day 3 Recap https://t.co/ZQ1mZePZ1S
RheumNow
ACR25 Best Abstracts – Day 3
ACR25 Best Abstracts – Day 3 jjcush@gmail.com Tue, 10/28/2025 – 17:45
RheumNow
Disease activity associated with symtomatic knee OA and increased with increased KL grades Abst#2625 #ACR25 @RheumNow ht
Disease activity associated with symtomatic knee OA and increased with increased KL grades Abst#2625 #ACR25 @RheumNow ht https://pbs.twimg.com/profile_images/1248272740831735809/C0SA-iJf_normal.jpg john+RNV2@john… Tue,
RheumNow
Accelerated Aging in Rheumatic Disease: From Biology to Lifestyle Intervention
Accelerated Aging in Rheumatic Disease: From Biology to Lifestyle Intervention leefam59@gmail.com Tue, 10/28/2025 – 17:24
RheumNow
Head to head study of Secukinumab vs Ustekinumab. In TNFi-experienced PsA patients, the AgAIN trial shows secukinumab pe
Head to head study of Secukinumab vs Ustekinumab. In TNFi-experienced PsA patients, the AgAIN trial shows secukinumab pe https://pbs.twimg.com/profile_images/926606033270665216/Z42VohYE_normal.jpg john+RNV2@john…
RheumNow
A deep dive into Lupus 🔬 Abstract 2601: Single-cell insights in SLE & pre-clinical autoimmunity 🔹 Plasmablast
A deep dive into Lupus 🔬 Abstract 2601: Single-cell insights in SLE & pre-clinical autoimmunity 🔹 Plasmablast https://pbs.twimg.com/profile_images/1590198200824000512/8_JyVKFt_normal.jpg john+RNV2@john… Tue,
RheumNow
CDAI appropriately guided therapy escalation in RA, but not for everyone. Treatment adjustments were less likely in pts
CDAI appropriately guided therapy escalation in RA, but not for everyone. Treatment adjustments were less likely in pts https://pbs.twimg.com/profile_images/1525262133575012354/Lfut18gD_normal.jpg john+RNV2@john…
RheumNow
Abstract 2360: Single-center lupus pregnancy cohort found that: 🔹 Absence of DORIS remission associated w/ adverse pr
Abstract 2360: Single-center lupus pregnancy cohort found that: 🔹 Absence of DORIS remission associated w/ adverse pr https://pbs.twimg.com/profile_images/1590198200824000512/8_JyVKFt_normal.jpg john+RNV2@john… Tue,
RheumNow
Reaadmissions in sle pregnancies from 66k patients Insurance and economics seem to be very important in predictions usin
Reaadmissions in sle pregnancies from 66k patients Insurance and economics seem to be very important in predictions usin https://pbs.twimg.com/profile_images/1248272740831735809/C0SA-iJf_normal.jpg john+RNV2@john…
Disparities in Physical Function in SLE
Disparities in Physical Function in SLE tammytilley@gm… Tue, 10/28/2025 – 16:45 Lupus Drs. Mrinalini Dey and Laura Plantinga discuss abstracts
Novel Insights into Sjogren’s Disease
Novel Insights into Sjogren’s Disease tammytilley@gm… Tue, 10/28/2025 – 16:39 General Rheumatology Sjogrens Dr. Janet Pope reporting on abstract 1684
The Power of Gamma Delta T Cell for Autoimmunity
The Power of Gamma Delta T Cell for Autoimmunity tammytilley@gm… Tue, 10/28/2025 – 14:55 Education/ACR/EULAR Lupus Drs. Yuz Yusof and
RheumNow
Adverse events from avacopan the WHO pharmacovigilence database (VigiBase) Not a lot new – infections happen, hepatic e
Adverse events from avacopan the WHO pharmacovigilence database (VigiBase) Not a lot new – infections happen, hepatic e https://pbs.twimg.com/profile_images/1982460526815764480/EQEuBdmh_normal.jpg john+RNV2@john…
RheumNow
Are the clues of RA there in the EMR, before the diagnosis is made? Jina off-the-shelf AI with subsequent retraining fo
Are the clues of RA there in the EMR, before the diagnosis is made? Jina off-the-shelf AI with subsequent retraining
RheumNow
In a 4-year study of 85 SpA patients, ChatGPT-4o matched SPSS in analyzing NLR/PLR trends. Outputs were identical, but C
In a 4-year study of 85 SpA patients, ChatGPT-4o matched SPSS in analyzing NLR/PLR trends. Outputs were identical, but C
RheumNow
Eder et al. Deucravacitinib in PsA from POETYK-PsA stuides. Male and female patients had similar response rates at week
Eder et al. Deucravacitinib in PsA from POETYK-PsA stuides. Male and female patients had similar response rates at week https://pbs.twimg.com/profile_images/1389468430160510976/sooz0Ud3_normal.jpg
RheumNow
In the CLOSE-UP study of UPA in RA – 61% in remission with responses sustained to 24 mo – Benefit consistent irrespectiv
In the CLOSE-UP study of UPA in RA – 61% in remission with responses sustained to 24 mo – Benefit